Adjournment

OpGen Announces Partial Adjournment of Annual Meeting

Retrieved on: 
Wednesday, July 7, 2021

The Company adjourned the Annual Meeting with respect to such proposal to provide its stockholders additional time to vote on Proposal 2.

Key Points: 
  • The Company adjourned the Annual Meeting with respect to such proposal to provide its stockholders additional time to vote on Proposal 2.
  • * The record date for determining stockholders eligible to vote at the Annual Meeting will remain the close of business on April 15, 2021.
  • * As part of our precautions regarding the coronavirus (or COVID-19) pandemic, we are planning for the possibility that we may need to change the location of the Annual Meeting, or the Annual Meeting may be held solely by means of remote communication.
  • This press release includes statements regarding the partial adjournment of OpGens Annual Meeting.

Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting

Retrieved on: 
Wednesday, June 30, 2021

- 49% of shares voted, quorum not established to hold annual meeting

Key Points: 
  • - 49% of shares voted, quorum not established to hold annual meeting
    - Meeting scheduled to reconvene August 3, 2021 at 9:00 AM EDT
    DEVON, Pa., June 30, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that it has adjourned its 2021 Annual Meeting of Stockholders due to a lack of quorum.
  • The reconvened annual meeting will also be a "virtual" meeting of stockholders.
  • The record date for the annual meeting continues to be April 14, 2021.
  • Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.

CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting

Retrieved on: 
Friday, June 25, 2021

CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, invites participants to pre-submit questions for the Companys upcoming Annual Shareholder Meeting to be held on July 1, 2021 at 10:00 a.m. EDT.

Key Points: 
  • CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, invites participants to pre-submit questions for the Companys upcoming Annual Shareholder Meeting to be held on July 1, 2021 at 10:00 a.m. EDT.
  • After the business portion of the annual meeting concludes and the meeting is adjourned, CEL-SCI will do its best to address pre-submitted questions and reserves the right to exclude questions that are not pertinent to annual meeting matters.
  • Due to the concerns about the COVID-19 pandemic, CEL-SCIs annual meeting will be held as a hybrid meeting, both at 8229 Boone Blvd., Suite 802, Vienna, VA 22182 and as a virtual meeting.
  • We strongly advise you to attend the meeting via the virtual annual shareholder meeting.

PharmaCyte Biotech Announces Adjournment of Annual Meeting of Stockholders, Recording of Stockholder Meeting Available

Retrieved on: 
Friday, June 18, 2021

The meeting was adjourned in order to allow additional time for stockholders to vote on Proposal No.

Key Points: 
  • The meeting was adjourned in order to allow additional time for stockholders to vote on Proposal No.
  • When the annual meeting is reconvened on June 30, 2021, it will continue to be held virtually at www.virtualshareholdermeeting.com/PMCB2021 .
  • 2 is critical for the Company to remain viable and for its pancreatic cancer therapy to remain in development and avoid being shelved.
  • To listen to the Companys shareholder meeting that took place on June 16, 2021, click this link: www.virtualshareholdermeeting.com/PMCB2021 .

MTS Announces 2021 Extraordinary General Meeting of Shareholders to Approve Merger with SharpLink, Inc. and Related Proposals

Retrieved on: 
Wednesday, June 16, 2021

To approve the adoption of the new SharpLink, Ltd. 2021 Equity Incentive Plan and the reservation of 4,673,264 Ordinary Shares for issuance thereunder; and

Key Points: 
  • To approve the adoption of the new SharpLink, Ltd. 2021 Equity Incentive Plan and the reservation of 4,673,264 Ordinary Shares for issuance thereunder; and
    j.
  • To transact any other business that may be properly brought before the Meeting or any continuation, adjournment or postponement thereof.
  • Eligible shareholders may present proper proposals for inclusion in the Meeting by submitting their proposals to the Company no later than June 23, 2021.
  • Headquartered in Israel, MTS markets its solutions through wholly-owned subsidiaries in Israel, the U.S. and Hong Kong, as well as through distribution channels.

Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting

Retrieved on: 
Wednesday, June 9, 2021

46.4% of shares voted, quorum not established to hold annual meeting

Key Points: 
  • 46.4% of shares voted, quorum not established to hold annual meeting
    Meeting scheduled to reconvene June 29, 2021 at 9:00 AM EDT
    DEVON, Pa., June 09, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that it has adjourned its 2021 Annual Meeting of Stockholders due to a lack of quorum.
  • The reconvened annual meeting will also be a "virtual" meeting of stockholders.
  • The record date for the annual meeting continues to be April 14, 2021.
  • Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.

Asensus Surgical 2021 Annual Meeting of Stockholders Is Adjourned

Retrieved on: 
Thursday, June 3, 2021

Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, today announced that the Companys 2021 Annual Meeting of Stockholders, scheduled to be held on Thursday, June 3, 2021 at 3:00 p.m. (Eastern Time), was adjourned to Tuesday, June 29, 2021 at 11:00 a.m. (Eastern Time).

Key Points: 
  • Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, today announced that the Companys 2021 Annual Meeting of Stockholders, scheduled to be held on Thursday, June 3, 2021 at 3:00 p.m. (Eastern Time), was adjourned to Tuesday, June 29, 2021 at 11:00 a.m. (Eastern Time).
  • The Company adjourned the Annual Meeting to allow its retail stockholders additional time to consider and vote on each of the proposals, which are described in the Proxy Statement.
  • Stockholders who have sold their shares but were a holder of record at the close of business on April 8, 2021, the record date for the Annual Meeting, remain entitled to vote.
  • Proxies submitted to date for the Annual Meeting continue to be valid and will be voted at the Annual Meeting on June 29, 2021 in accordance with the stockholders instructions.

Notice of the Twenty-second Annual General Meeting of Shareholders

Retrieved on: 
Friday, May 28, 2021

To transact any other business as may properly be transacted at an Annual General Meeting of the Company.

Key Points: 
  • To transact any other business as may properly be transacted at an Annual General Meeting of the Company.
  • Shareholders are cordially invited to attend the Twenty-Second Annual General Meeting in person.
  • Whether or not you plan to be at the Twenty- Second Annual General Meeting, you are urged to return your proxy.
  • Only shareholders of record at the close of business on April 23, 2021 are entitled to notice of and to vote at the Twenty- Second Annual General Meeting, or any adjournment or postponement of the Twenty- Second Annual General Meeting.

Golden Minerals Announces Intent to Adjourn 2021 Annual Meeting of Stockholders

Retrieved on: 
Thursday, May 13, 2021

b'GOLDEN, Colo., May 13, 2021 (GLOBE NEWSWIRE) -- Golden Minerals Company (NYSE American and TSX: AUMN) (\xe2\x80\x9cGolden Minerals\xe2\x80\x9d, \xe2\x80\x9cGolden\xe2\x80\x9d or \xe2\x80\x9cthe Company\xe2\x80\x9d) announced today that it intends to call to order and then immediately adjourn its virtual annual meeting of stockholders commencing Thursday May 13, 2021, at 1:00 p.m. Mountain Time.

Key Points: 
  • b'GOLDEN, Colo., May 13, 2021 (GLOBE NEWSWIRE) -- Golden Minerals Company (NYSE American and TSX: AUMN) (\xe2\x80\x9cGolden Minerals\xe2\x80\x9d, \xe2\x80\x9cGolden\xe2\x80\x9d or \xe2\x80\x9cthe Company\xe2\x80\x9d) announced today that it intends to call to order and then immediately adjourn its virtual annual meeting of stockholders commencing Thursday May 13, 2021, at 1:00 p.m. Mountain Time.
  • The adjournment of the virtual annual meeting of stockholders will be until 1:00 p.m. (Mountain Time) on June 10, 2021.
  • Stockholders of record may submit their votes for matters to be considered at the annual meeting until the polls are formally closed.
  • Additional risks relating to Golden Minerals may be found in the periodic and current reports filed with the SEC by Golden Minerals, including the Company\xe2\x80\x99s Annual Report on Form 10-K for the year ended December 31, 2020.\n'

Utz Brands, Inc. Announces Intent to Adjourn 2021 Annual Meeting of Stockholders

Retrieved on: 
Wednesday, May 5, 2021

The adjournment of the virtual annual meeting of stockholders will be until 9:00 a.m., Eastern Time on Thursday, May 20, 2021 to be accessed by visiting www.virtualshareholdermeeting.com/Utz2021 .

Key Points: 
  • The adjournment of the virtual annual meeting of stockholders will be until 9:00 a.m., Eastern Time on Thursday, May 20, 2021 to be accessed by visiting www.virtualshareholdermeeting.com/Utz2021 .
  • The Company currently expects to file the amended 2020 Annual Report on or about Thursday, May 13, 2021.
  • Eligible stockholders may participate in and vote at the Annual Meeting by following the instructions available on the meeting website during the meeting.
  • Stockholders of record may submit their votes for matters to be considered at the annual meeting until the polls are formally closed.